Clinical Trial: A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07081334) titled 'A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine' on June 30.

Brief Summary: Study Title:

Evaluation of the Safety and Immunogenicity of a Third Dose of PV-001 in Healthy Women Aged 19-45

Objective:

To assess the safety and antibody response of a third dose of PV-001 in healthy adult female participants.

Key Questions Is PV-001 safe? What adverse events may occur after vaccination? Does PV-001 produce an effective immune response?

Participant Activities :

Three clinic visits for screening and vaccination Blood samples collected on a set schedule Monitoring for side effects after vaccination

Study Start Dat...